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A 12 year old boy presented with non syndromic mental retardation. Brain MRI showed 
schizencephaly with a deep right parietooccipital cleft extending from cortical surface to the 
occipital horn of cerebral ventricle. Moreover his family was known for antithrombin III 
deficiency linked to the homozygous c.391C>T (p.Leu131Phe) mutation in SERPINC1. 
Coagulation studies revealed in this young boy severe antithrombin III deficiency and molecular 
analysis confimed the mutation.  
Discussion 
Schizencephaly can be considered as cerebral malformation of neuronal migration, caused by 
mutations in several transcription factors, but most cases occur sporadically and are believed to 
be associated with a vascular disruptive mechanism. In the proband, analysis of the SHH, SIX3 
and EMX2 genes showed no mutation. Porencephaly and schizencephaly have also been 
attributed to mutations of COL4A1, linking, as in our case, genetic vascular pathology with 
schizencephaly.  Otherwise mutations of methylterahydrofolate reductase and factor V Leiden 
genes seems also responsible of cases of  schizencephaly. We suggest that a similar 
encephaloclastic mechanism took place in our patient and hypothesize the occurrence of an 
early antenatal cerebral vascular injury.  
Conclusion 
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